- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 97
Groww to expand with $251m series E
The online investment platform developer tripled its valuation to $3bn in a round that included Propel Venture Partners.
Oct 25, 2021Daily Deal Round Up: October 22, 2021
Automated driving software developer Jimu Intelligent raised over $31m from investors including UMC Capital and Avic Pingshan while Lockheed Martin took part in gyroscope technology developer Anello's $28m round.
Oct 22, 2021Clounix closes two rounds
The networking technology developer raised $62.6m between an Inspur Group-backed angel round and a pre-series A.
Oct 22, 2021D&D Pharmatech decides on $51m series C
Sumitomo Mitsui’s DS Asset Management subsidiary backed the neurological and metabolic disorder drug developer in a round that will support clinical trials.
Oct 22, 2021ShouTi shoots to $100m series B round
Eli Lilly, WuXi AppTec and Schrodinger were among the investors in the cardiovascular, pulmonary and metabolic disorder drug developer's latest round.
Oct 22, 2021Daily Deal Round Up: October 21, 2021
Battery swapping service Sun Mobility closed $50m in funding from Vitol while Sinopharm-backed drug developer Sinotau raised the same amount in a series D-plus round.
Oct 21, 2021Dreame hoovers up $563m in funding
Xiaomi returned for the smart home appliance producer’s series C round, which also featured Country Garden Ventures.
Oct 21, 2021Huahui Health treats itself to $78m
The WuXi AppTec-backed hepatitis specialist replenished its coffers in a series A-plus round led by Hillhouse Capital fund GL Capital.
Oct 21, 2021Richland Capital Fund III closes at $109m
The Redbud Capital-backed new materials-focused vehicle has attained its target, more than a year after a first close.
Oct 21, 2021Daily Deal Round Up: October 20, 2021
MS&AD Ventures and Mouro Capital helped privacy management technology provider Skyflow secure $45m while neurotherapeutics developer Cecerin revealed $40m from investors including Nestlé.
Oct 20, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


